Metraipolis › archive › dc_ec452ee95263
Comprehensive disproportionality analysis of individual case safety reports associated with Janus kinase inhibitors in psoriasis and psoriatic arthritis using… — Europe PMC PMID:41112262
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41112262
- DOI
- 10.3389/fimmu.2025.1629886
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T14:46:06.015Z
- SHA-256 of the archived text
08056d1a2fb85a3efed68488452f49ed9bb3f3e600936f31ef4d537551fdf83e- Stable URL of this page
https://metraipolis.com/documento/dc_ec452ee95263
How to cite
Comprehensive disproportionality analysis of individual case safety reports associated with Janus kinase inhibitors in psoriasis and psoriatic arthritis using… — Europe PMC PMID:41112262 — Europe PMC (en), https://europepmc.org/article/MED/41112262 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ec452ee95263 (Metraipolis archive dc_ec452ee95263, sha256 08056d1a2fb85a3efed68488452f49ed9bb3f3e600936f31ef4d537551fdf83e)
BibTeX
@misc{dcec452ee95263,
title = {Comprehensive disproportionality analysis of individual case safety reports associated with Janus kinase inhibitors in psoriasis and psoriatic arthritis using… — Europe PMC PMID:41112262},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41112262},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ec452ee95263; sha256 08056d1a2fb85a3efed68488452f49ed9bb3f3e600936f31ef4d537551fdf83e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41112262. Agents can read the archived copy with the MCP tool read_document.